This inventor holds 2 USPTO granted patents. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 1977-1981.
Location History:
- Tsuzuki, JA (1977)
- Yawata, JP (1981)
Company Filing History:
Years Active: 1977-1981
Title: Hiroaki Kinugasa: Innovator in Antihypertensive Compounds
Introduction
Hiroaki Kinugasa is a notable inventor based in Tsuzuki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antihypertensive compounds. With a total of 2 patents, his work has garnered attention for its potential therapeutic benefits.
Latest Patents
Kinugasa's latest patents include innovative compounds that demonstrate excellent antihypertensive activity. One of his notable inventions is the 1-(3-Mercapto-2-methylpropanoyl)prolyl amino acid derivatives and salts. This compound features a complex formula where R represents various groups, and it has shown promising results in managing hypertension. Another significant patent is the 3-Piperazinyl 1,2,4-benzothiadiazine 1,1-dioxide derivatives. This compound is designed to provide antihypertensive effects while minimizing side effects associated with other treatments.
Career Highlights
Hiroaki Kinugasa is associated with Dainippon Pharmaceutical Company, Limited, where he has been instrumental in advancing research and development in antihypertensive medications. His expertise in the field has led to the creation of compounds that are not only effective but also safe for patients.
Collaborations
Kinugasa has collaborated with esteemed colleagues such as Haruki Nishimura and Katsuyoshi Nakatsuzi. These partnerships have fostered a collaborative environment that enhances innovation and the development of new pharmaceutical solutions.
Conclusion
Hiroaki Kinugasa's contributions to the field of antihypertensive compounds highlight his role as a significant inventor in the pharmaceutical industry. His innovative work continues to pave the way for advancements in hypertension treatment.